Digestiva
Davis, US · Delaware corporation · 1 known investors
Digestiva develops proprietary protease enzymes that break down proteins to produce more bioaccessible and smaller peptides, increase free amino acid availability, and improve protein yield from co-products and waste streams. Its technology targets applications in health, nutrition, and food processing.
Founders & leadership
JH
Julie HirschExecutive
JM
John MeloExecutive
JS
Justin SiegelNamed on SEC filing
Board
HS
IA
Irina AdlerBoard director
GP
George PowlickBoard director
JL
Jorge LealBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$18.4M disclosed across 1 round · 2024
▶$18.4MraisedJul 2024 · 5 investors · Other Health CareRule 506(b)
▶$18.4MraisedJul 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Irina AdlerDirector
- George PowlickDirector
- Harold SchmitzDirector
- Justin SiegelExecutive Officer
- Julie HirschExecutive Officer
- John MeloExecutive Officer, Director
- Jorge LealDirector
- Offering amount
- $19.4M
- Amount sold
- $18.4M
- Minimum investment
- $1
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Digestiva do?
- Digestiva develops proprietary protease enzymes that break down proteins to produce more bioaccessible and smaller peptides, increase free amino acid availability, and improve protein yield from co-products and waste streams. Its technology targets applications in health, nutrition, and food processing.
- Who are Digestiva's investors?
- Digestiva's investors include The March Group.
- How much funding has Digestiva raised?
- Digestiva has disclosed $18.4M raised across 1 round.
- Where is Digestiva headquartered?
- Digestiva is headquartered in Davis, US.